Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist. | J Pain | 2021 | 33429107 | PubTator, text mining | PubMed |
| DNA methylation signatures of aggression and closely related constructs: A meta-analysis of epigenome-wide studies across the lifespan. | Mol Psychiatry | 2021 | 33420481 | PubTator, text mining | PubMed |
| Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma. | Sci Rep | 2021 | 33420101 | PubTator, text mining | PubMed |
| Thrombin generation and activity in multiple sclerosis. | Metab Brain Dis | 2021 | 33411219 | PubTator, text mining | PubMed |
| Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review. | J Clin Med | 2021 | 33406783 | PubTator, text mining | PubMed |
| LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network. | Int J Med Sci | 2021 | 33390811 | PubTator, text mining | PubMed |
| Predictive value of protease-activated receptor-2 (PAR2 ) in cervical cancer metastasis. | J Cell Mol Med | 2021 | 33369107 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity? | Cardiovasc Drugs Ther | 2021 | 33337519 | PubTator, text mining | PubMed |
| Protease-activated receptor 1 as a potential therapeutic target for COVID-19. | Exp Biol Med (Maywood) | 2021 | 33302737 | PubTator, text mining | PubMed |
| Thrombin in peripheral nerves: friend or foe? | Neural Regen Res | 2021 | 33269786 | PubTator, text mining | PubMed |
| Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis. | Arterioscler Thromb Vasc Biol | 2021 | 33267659 | PubTator, text mining | PubMed |
| Brain injury and repair after intracerebral hemorrhage: The role of microglia and brain-infiltrating macrophages. | Neurochem Int | 2021 | 33248206 | PubTator, text mining | PubMed |
| Compartmentalized GPCR Signaling from Intracellular Membranes. | J Membr Biol | 2021 | 33231722 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation. | J Crohns Colitis | 2021 | 33201214 | PubTator, text mining | PubMed |
| Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction. | Arterioscler Thromb Vasc Biol | 2021 | 33176447 | PubTator, text mining | PubMed |
| Protease-activated receptor 4 plays a role in lipopolysaccharide-induced inflammatory mechanisms in murine macrophages. | Naunyn Schmiedebergs Arch Pharmacol | 2021 | 33159803 | PubTator, text mining | PubMed |
| Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans. | J Thromb Thrombolysis | 2021 | 33159252 | PubTator, text mining | PubMed |
Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs). | Cancer Immunol Immunother | 2021 | 33146401 | PubTator, text mining | PubMed |
| Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling. | Neurosci Bull | 2021 | 33111257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=32